HEART FAILURE REVIEWS

Scope & Guideline

Elevating Standards in Cardiac Care and Research

Introduction

Immerse yourself in the scholarly insights of HEART FAILURE REVIEWS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1382-4147
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1996 to 2024
AbbreviationHEART FAIL REV / Heart Fail. Rev.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal "Heart Failure Reviews" aims to provide comprehensive insights into various aspects of heart failure, focusing on advancements in treatment, diagnosis, and management strategies. It encompasses a wide range of topics, including clinical studies, systematic reviews, and innovative therapies, making significant contributions to the field of cardiology.
  1. Clinical Management of Heart Failure:
    The journal emphasizes the importance of clinical management strategies for heart failure, including pharmacological treatments, lifestyle interventions, and the use of advanced therapies such as device management and surgical options.
  2. Innovative Therapeutic Approaches:
    Research published in the journal often explores novel therapeutic approaches, such as the use of SGLT2 inhibitors, GLP-1 receptor agonists, and other emerging drugs, highlighting their efficacy and mechanisms in heart failure management.
  3. Diagnosis and Prognosis:
    The journal focuses on advancements in diagnostic techniques, including echocardiography, cardiac MRI, and biomarkers, as well as prognostic tools that aid in assessing heart failure severity and outcomes.
  4. Pathophysiology and Mechanisms:
    A significant portion of the articles delve into the underlying mechanisms and pathophysiology of heart failure, including molecular, genetic, and inflammatory aspects that contribute to disease progression.
  5. Comorbidities and Multidisciplinary Care:
    The journal promotes the understanding of comorbid conditions associated with heart failure, advocating for a multidisciplinary approach to patient care that addresses both cardiac and non-cardiac issues.
The journal has shown an evolving focus on emerging trends and novel therapeutic approaches in heart failure management. Recent publications reflect a growing interest in integrating technology, personalized medicine, and innovative pharmacotherapies.
  1. Digital Health and Telemonitoring:
    The integration of digital health technologies and telemonitoring for heart failure management is increasingly highlighted, showcasing the potential for improving patient outcomes through remote monitoring and engagement.
  2. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research on HFpEF is gaining traction, with a focus on its unique challenges, therapeutic options, and the development of specific management guidelines, reflecting a better understanding of this complex condition.
  3. Personalized and Precision Medicine:
    There is a growing trend towards personalized medicine in heart failure treatment, with an emphasis on tailoring therapies based on genetic, molecular, and phenotypic characteristics of patients.
  4. Innovative Biomarkers and Diagnostic Tools:
    The exploration of novel biomarkers and advanced diagnostic tools, such as cardiac imaging techniques and machine learning algorithms, is becoming more prevalent, enhancing the ability to stratify risk and personalize treatment.
  5. Impact of Lifestyle Modifications:
    Recent publications increasingly emphasize the significance of lifestyle modifications, including dietary and exercise interventions, as integral components of heart failure management.

Declining or Waning

While the journal continues to thrive in many areas, certain themes appear to be losing prominence in recent publications. This may reflect shifts in research focus or advancements in treatment options that have rendered some topics less critical or outdated.
  1. Traditional Pharmacological Approaches:
    There seems to be a decreasing emphasis on traditional pharmacological treatments such as ACE inhibitors and beta-blockers, as newer therapies like SGLT2 inhibitors gain prominence in heart failure management.
  2. Isolated Studies on Specific Comorbidities:
    Research focusing solely on specific comorbidities without integrating them into a broader heart failure management context is becoming less frequent, indicating a shift towards more holistic approaches.
  3. Generalized Risk Factors:
    Articles that discuss generalized risk factors for heart failure without specific context or innovative approaches are appearing less often, as the field moves towards more targeted and individualized treatment strategies.

Similar Journals

International Heart Journal

Empowering Healthcare Professionals with Cutting-edge Insights
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

World Journal of Cardiology

Empowering the future of cardiovascular science.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1949-8462Frequency: 12 issues/year

World Journal of Cardiology, published by BAISHIDENG PUBLISHING GROUP INC, stands out as a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1949-8462, this journal serves a global audience, promoting knowledge dissemination and collaboration among researchers, healthcare professionals, and students dedicated to advancing cardiovascular health. The journal demonstrates its credibility and impact in the field by achieving a respectable Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine. Notably, it is listed in the Scopus database, ranking #189 out of 387 journals, placing it in the 51st percentile, which underscores its relevance and contribution to contemporary cardiovascular research. Although it operates under a subscription model, the journal provides diverse access options, ensuring that critical findings reach a wide audience. Through its comprehensive scope and commitment to publishing high-quality articles, the World Journal of Cardiology plays a vital role in shaping the future of cardiovascular science, making it an invaluable asset for those involved in this essential discipline.

Minerva Cardiology and Angiology

Transforming cardiovascular practices with cutting-edge findings.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-5683Frequency: 6 issues/year

Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.

Netherlands Heart Journal

Bridging Research and Practice in the World of Cardiovascular Medicine
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

Cardiac Failure Review

Exploring breakthroughs in cardiac failure management.
Publisher: RADCLIFFE CARDIOLOGYISSN: 2057-7540Frequency: 1 issue/year

Cardiac Failure Review, published by Radcliffe Cardiology, is a leading open-access journal dedicated to advancing the understanding and management of cardiac failure. With an ISSN of 2057-7540 and an E-ISSN of 2057-7559, this journal has gained significant recognition in the field, achieving a Q1 ranking in Cardiology and Cardiovascular Medicine as of 2023. Its impressive positioning at rank #97 out of 387 in Scopus further highlights its impact, placing it within the top 25th percentile of its category. Since transitioning to open access in 2019, Cardiac Failure Review has become increasingly accessible, ensuring that critical research findings are available to a global audience. The journal's focus spans innovative treatments, emerging technologies, and comprehensive reviews, effectively meeting the needs of researchers, clinicians, and students alike. With a commitment to excellence in cardiovascular medicine, Cardiac Failure Review plays a vital role in disseminating knowledge and fostering discussions that drive the field forward.

CARDIOLOGY CLINICS

Shaping the future of heart health through rigorous research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8651Frequency: 4 issues/year

CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.

Hellenic Journal of Cardiology

Pioneering Insights in Cardiovascular Health Since 1993
Publisher: ELSEVIERISSN: 1109-9666Frequency: 6 issues/year

The Hellenic Journal of Cardiology, a peer-reviewed open-access publication under the esteemed ELSEVIER banner, proudly represents the forefront of research in the field of Cardiology and Cardiovascular Medicine. Established in 1993 and actively publishing since then, this journal has carved a niche in disseminating high-quality research and clinical insights relevant to cardiovascular health in Greece and beyond. With an impressive Q2 ranking in both Cardiology and Cardiovascular Medicine categories as of 2023, the journal holds a commendable position at Rank #126/387 in Scopus, indicative of its critical role in advancing scientific knowledge and practice. The Hellenic Journal of Cardiology transitioned to open access in 2016, ensuring that ground-breaking research is freely accessible, fostering a global dialogue among researchers, clinicians, and students alike. Its publication frequency spans significant years, providing a continuous flow of innovative findings while addressing pressing cardiovascular issues. As the journal builds on its legacy, it aspires to enrich the academic community's understanding of cardiovascular medicine, making it an invaluable resource for anyone invested in heart health.

CURRENT OPINION IN CARDIOLOGY

Shaping the future of cardiology through expert commentary.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0268-4705Frequency: 6 issues/year

CURRENT OPINION IN CARDIOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed journal in the field of cardiology that has been serving the academic community since 1988. With a robust focus on the latest developments and emerging trends in cardiovascular medicine, this journal aims to bridge the gap between clinical practice and research, offering critical insights and expert commentary. The journal is recognized in the medical community, achieving a 2023 Scopus rank of #148 out of 387 in its category, placing it in the 61st percentile. Although it operates under a subscription-based model, CURRENT OPINION IN CARDIOLOGY remains an essential resource for researchers, practitioners, and students seeking cutting-edge knowledge and advancements in cardiology. As a Q2 journal in the field, it continues to foster dialogue and provide a platform for disseminating impactful cardiovascular research, ultimately contributing to improved patient outcomes and informed clinical decisions.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES

Innovating Techniques for Heart Health
Publisher: WILEYISSN: 0742-2822Frequency: 12 issues/year

ECHOCARDIOGRAPHY: A Journal of Cardiovascular Ultrasound and Allied Techniques is a premier scholarly publication committed to advancing the field of cardiovascular imaging through the dissemination of high-quality research and clinical studies. Published by Wiley, this journal has been a vital resource since its inception in 1984, aiming to bridge the gap between ultrasound techniques and clinical practice over its converged years extending to 2024. With an ISSN of 0742-2822 and an E-ISSN of 1540-8175, the journal is indexed in notable databases and holds a respectable standing in its field, reflected in its Q3 rankings in Cardiovascular Medicine, Miscellaneous Medicine, and Radiology for 2023. Though currently not open access, the journal strives to provide valuable insights and innovative techniques to researchers, professionals, and students alike, fostering a deeper understanding of echocardiography and its impact on patient care. Located in the United States, the journal continues to serve as a cornerstone for contemporary cardiovascular research and education, ensuring that the latest advancements and practices are readily accessible to the medical community.

HEART AND VESSELS

Transforming Heart Health Through Scholarly Excellence
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.